Adoption Of The Point Of Care Testing For Quick Diagnosis And Guiding To Doctor Are Expected To Boost The Demand Of Chromosomal Aberration Testing Among Healthcare Professionals

Chromosomal aberration is a structural abnormality in one or more chromosomes. Several mutagenic agents are frequently exposed to the human population, they have potential to damage the DNA. In many cases result in the form of chromosomal aberration. Chromosomal aberration is majorly 4 type deletion, duplication, inversion, and translocation. Induced chromosomal aberrations can be classified into two main classes – chromosome type aberration and chromatids type aberrations. Chromosomal aberration includes rearrangement, breakage and numerical changes which play important role in cancer formation, heritable mutation, developmental abnormalities and embryonic loss. The most common type of chromosomal abnormality is aneyploidy. Chromosomal aberration test procedures importance is increasing with time for determination of genetic risk, DNA, and chromosomal structure changes. Chromosomal aberration tests performed in vitro and in vivo which are designed to detect compounds that include DNA damage. Basically test using mammalian cells is used to identify causative agents of structural changes in chromosomes. Chromosomal aberration test involves the real-time analysis of chromosomes to identify structural and sequential variation.

Request for Brochure of this Report: http://www.factmr.com/connectus/sample?flag=B&rep_id=1160

Increasing awareness about chromosomal aberration test among people suffering from genetic and chromosomal disorders is expected to drive the demand of Chromosomal Aberration Test Market. Growing number of people suffering from genetic disorders are expected to increase demand for chromosomal aberration testing procedures in order to have a healthy baby. Increasing application for chromosomal aberration testing for the diagnosis of disorders like minor disabilities like deafness and cancer expected to create high growth opportunities for chromosomal aberration test market players. Increasing birth abnormalities, adoption of genetic counseling, increasing rate of prenatal diagnosis and fertility treatment are some of the major driving factors of chromosomal aberration test market. Adoption of the point of care testing for quick diagnosis and guiding to doctor are expected to boost the demand of chromosomal aberration testing among healthcare professionals. There are some technical limitations like the higher cost of services, failure to detect abnormal results, standardization and poor test results in case of the contaminated sample. The high cost of testing and limited reimbursement policies is restraining the growth of chromosomal aberration test market.

The global chromosomal aberration test market is segmented on basis of test type, end user and region:

• Segmentation by Test Type
  • Mammalian Chromosome Aberration Test
  • Genetic Toxicity Testing
  • Cytogenetic Testing
  • Bacterial Reverse Mutation Test
• Segmentation by End User
  • Hospitals
  • Diagnosis Laboratories
  • Fertility and Maternity Centers
  • Research Centers

Chromosomal aberration test is designed to evaluate the potential of test to induce chromosomal abnormalities such as exchanges and breaks. Chromosomal aberration assays are also used to detect chemicals that induce chromosome damage, including complex chromosome change such as rings, exchanges & dicentrics and chromatid & chromosome breaks. The global chromosomal aberration market is expected to witness high growth over forecast period owing to increasing number of the treatment-seeking rate for the genetic problem or avoiding birth defects problems among babies.

Regionally, the global chromosomal aberration test market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific Excluding China, China, and Middle East & Africa. North America is expected to lead the global market owing to high awareness among people and presence of several end user providing chromosomal aberration testing services. Europe also shows second largest market in the chromosomal aberration test market due to rising prevalence of genetic problems and chromosomal aberration. However, the chromosomal aberration test market in the Asia-Pacific region is expected to witness significant growth rate in coming years due to increasing investments in fertilities and cancer care, increasing funding by government to curb the prevalence of birth deficiency and genetic disorders.

Browse full details about Chromosomal Aberration Test Market report: http://www.factmr.com/report/1160/chromosomal-aberration-test-market

Some of the players operating in the global chromosomal aberration test market are Charles River Laboratories, Inc., Covance Inc., Molecular Toxicology, Inc., Environmental bio-detection products inc., Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Abbott Laboratories and others.

Regional Analysis:
North America
Latin America
Europe
Asia Pacific Excluding China
China
Middle East & Africa
Report Highlights:

Shifting industry dynamics
In-depth market segmentation
Historical, current and projected industry size recent industry trends
Key competition landscape
Strategies of key players and product offerings
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:

11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

The post Adoption Of The Point Of Care Testing For Quick Diagnosis And Guiding To Doctor Are Expected To Boost The Demand Of Chromosomal Aberration Testing Among Healthcare Professionals appeared first on Latest Market Reports.